Panacea Biotec [PANACEABIO] vs Albert David [ALBERTDAVD] Detailed Stock Comparison

Panacea Biotec Ltd.

NSE
Loading...

Albert David Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Panacea Biotec Ltd. wins in 3 metrics, Albert David Ltd. wins in 16 metrics, with 0 ties. Albert David Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Panacea Biotec Ltd. Albert David Ltd. Better
P/E Ratio (TTM) 182.62 44.00 Albert David Ltd.
Price-to-Book Ratio 2.65 1.08 Albert David Ltd.
Debt-to-Equity Ratio 2.79 10.51 Panacea Biotec Ltd.
PEG Ratio -15.02 -0.17 Albert David Ltd.
EV/EBITDA -65.87 -38.84 Albert David Ltd.
Profit Margin (TTM) -1.29% 2.98% Albert David Ltd.
Operating Margin (TTM) 1.99% 9.34% Albert David Ltd.
EBITDA Margin (TTM) 1.99% 9.34% Albert David Ltd.
Return on Equity -1.01% 4.38% Albert David Ltd.
Return on Assets (TTM) -0.65% 3.36% Albert David Ltd.
Free Cash Flow (TTM) $-776.74M $-432.92M Albert David Ltd.
Dividend Yield N/A 1.86% N/A
1-Year Return 18.85% -15.89% Panacea Biotec Ltd.
Price-to-Sales Ratio (TTM) 3.61 1.32 Albert David Ltd.
Enterprise Value $19.26B $1.80B Panacea Biotec Ltd.
EV/Revenue Ratio 3.18 0.56 Albert David Ltd.
Gross Profit Margin (TTM) 58.88% 69.05% Albert David Ltd.
Revenue per Share (TTM) $99 $565 Albert David Ltd.
Earnings per Share (Diluted) $-1.28 $16.88 Albert David Ltd.
Beta (Stock Volatility) 0.14 0.12 Albert David Ltd.

Panacea Biotec Ltd. vs Albert David Ltd. Stock Performance Analysis

Loading Price Chart...

PANACEABIO
ALBERTDAVD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Panacea Biotec Ltd.0.90%-2.19%39.94%70.71%51.42%43.20%
Albert David Ltd.-0.59%4.33%0.07%7.01%-4.08%-2.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Panacea Biotec Ltd.18.85%307.76%44.67%440.21%276.43%141.23%
Albert David Ltd.-15.89%17.53%49.44%126.75%126.75%126.75%

Performance & Financial Health Analysis: Panacea Biotec Ltd. vs Albert David Ltd.

MetricPANACEABIOALBERTDAVD
Market Information
Market Cap i₹21.84B₹4.11B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i168,2119,456
90 Day Avg. Volume i144,1848,688
Last Close₹540.80₹721.35
52 Week Range₹292.40 - ₹647.00₹579.90 - ₹957.50
% from 52W High-16.41%-24.66%
All-Time High₹647.00 (Jun 09, 2026)₹1,753.95 (Sep 02, 2024)
% from All-Time High-16.41%-58.87%
Growth Metrics
Quarterly Revenue Growth0.01%0.08%
Quarterly Earnings Growth-0.12%0.08%
Financial Health
Profit Margin (TTM) i-0.01%0.03%
Operating Margin (TTM) i0.02%0.09%
Return on Equity (TTM) i-0.01%0.04%
Debt to Equity (MRQ) i2.7910.51
Cash & Liquidity
Book Value per Share (MRQ)₹134.77₹690.75
Cash per Share (MRQ)₹13.86₹498.03
Operating Cash Flow (TTM) i₹-1,511,860,000₹-111,139,000
Levered Free Cash Flow (TTM) i₹-83,700,000₹172.01M
Dividends
Last 12-Month Dividend Yield iN/A1.86%
Last 12-Month Dividend i₹0.00₹16.50

Valuation & Enterprise Metrics Analysis: Panacea Biotec Ltd. vs Albert David Ltd.

MetricPANACEABIO (Apr 24, 2026)ALBERTDAVD (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i182.6244.00
Forward P/E iN/AN/A
PEG Ratio i-15.02-0.17
Price to Sales (TTM) i3.611.32
Price to Book (MRQ) i2.651.08
Market Capitalization
Market Capitalization i₹21.84B₹4.11B
Enterprise Value i₹19.26B₹1.80B
Enterprise Value Metrics
Enterprise to Revenue i3.180.56
Enterprise to EBITDA i-65.87-38.84
Risk & Other Metrics
Beta i0.140.12
Book Value per Share (MRQ) i₹134.77₹690.75

Financial Statements Comparison: Panacea Biotec Ltd. vs Albert David Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPANACEABIO (2025)ALBERTDAVD (2025)
Revenue/Sales i4.93B3.43B
Cost of Goods Sold i2.36B1.18B
COGS % of Revenue i47.9%34.5%
Gross Profit i2.57B2.25B
Gross Margin i52.1%65.5%
Research & Development iN/A28.92M
Operating Income (EBIT) i-556.12M-28.11M
Operating Margin i-11.3%-0.8%
EBITDA i-76.28M133.11M
EBITDA Margin i-1.5%3.9%
Pre-Tax Income i-79.48M252.28M
Pre-Tax Income % of Revenue i-1.6%7.3%
Income Tax i7.71M80.27M
Income Tax % of Revenue i0.2%2.3%
Net Income (Profit) i-87.19M172.01M
Profit Margin i-1.8%5.0%

Balance Sheet & Liquidity Metrics

MetricPANACEABIO (2025)ALBERTDAVD (2025)
Cash & Equivalents i821.25M4.17M
Total Current Assets i5.45B3.54B
Total Current Assets % of Revenue i110.7%103.1%
Total Current Liabilities i3.67B1.04B
Total Current Liabilities % of Revenue i74.5%30.4%
Long-Term Debt i150.00M13.31M
Long-Term Debt % of Revenue i3.0%0.4%
Total Shareholders Equity i8.31B3.92B
Retained Earnings i7.80B2.49B
Retained Earnings % of Revenue i158.3%72.6%
Property, Plant & Equipment i5.43B100.54M

Cash Flow Statement Comparison

MetricPANACEABIO (2025)ALBERTDAVD (2025)
Operating Cash Flow i-1.51B-111.14M
Operating Cash Flow % of Revenue i-30.7%-3.2%
Capital Expenditures i-497.30M-145.72M
Free Cash Flow i-776.74M-432.92M
FCF Margin i-15.8%-12.6%
Debt Repayment i0N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPANACEABIOALBERTDAVD
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i61.25M5.71M
Float Shares i15.42M2.05M
% Held by Insiders i72.65%64.05%
% Held by Institutions i0.13%1.61%
% Held by Public i27.22%34.34%

Dividend Analysis & Yield Comparison: Panacea Biotec Ltd. vs Albert David Ltd.

MetricPANACEABIOALBERTDAVD
Last 12-Month Dividend i₹0.00₹16.50
Last 12-Month Dividend Yield iN/A1.86%
3-Year Avg Annual Dividend i₹0.00₹17.50
3-Year Avg Dividend Yield iN/A1.16%
3-Year Total Dividends i₹0.00₹52.50
Ex-Dividend DateN/AJul 25, 2025